Clinical subtypes and molecular characteristics of serrated polyposis syndrome

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 6, 2013, Pages 705-711

  Guarinos, Carla ^a   Sánchez Fortún, Cristina ^a   Rodríguez Soler, María ^a   Pérez Carbonell, Lucía ^a   Egoavil, Cecilia ^a   Juárez, Miriam ^a   Serradesanferm, Anna ^b   Bujanda, Luis ^c   Fernández Bañares, Fernando ^d   Cubiella, Joaquín ^e   de Castro, Luisa ^f   Guerra, Ana ^g   Aguirre, Elena ^h   Herreros de Tejada, Alberto ⁱ   Bessa, Xavier ^j   Herráiz, Maite ^k   Marín Gabriel, José Carlos ^l   Balmaña, Judith ^m   Cuatrecasas, Miriam ^b   Balaguer, Francesc ^b   Castells, Antoni ^b   Soto, José Luis ⁿ   Alenda, Cristina ^a   Payá, Artemio ^a   Jover, Rodrigo ^a   more..

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d HOSPITAL MÚTUA DE TERRASSA   (Spain)

^e Departments of Pathology and Gastroenterology   (Spain)

^f Gastroenterology Department   (Spain)

^g Universidad Pública de Navarra   (Spain)

^h HOSPITAL ARNAU DE VILANOVA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^j HOSPITAL DEL MAR   (Spain)

^k UNIVERSITY CLINIC OF NAVARRA   (Spain)

^l HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^m HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁿ HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

more..

Author keywords

Hypermethylation; Hyperplastic Polyps; Molecular Markers; Serrated Polyps

Indexed keywords

B RAF KINASE; K RAS PROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DEMOGRAPHY; FAMILY HISTORY; FEMALE; GENDER AND SEX; GENE FREQUENCY; GENE MUTATION; HUMAN; MALE; MULTICENTER STUDY; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SERRATED POLYPOSIS SYNDROME; SMOKING;

ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 84878337371     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.12.045     Document Type: Article

References (28)

1. Boparai K.S., Reitsma J.B., Lemmens V., et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010, 59:1222-1225.
2. Snover D.C., Ahnen D.J., Burt R.W., et al. Serrated polyps of the colon and rectum and serrated ("hyperplastic") polyposis. WHO classification of tumours of the digestive system 2010, Springer-Verlag, Berlin. S.T. Bosman, F. Carneiro, R.H. Hruban (Eds.).
3. Boparai K.S., Mathus-Vliegen E.M., Koornstra J.J., et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010, 59:1094-1100.
4. Young J., Jass J.R. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 2006, 15:1778-1784.
5. Guarinos C., Sánchez-Fortún C., Rodríguez-Soler M., et al. Serrated polyposis syndrome: molecular, pathological and clinical aspects. World J Gastroenterol 2012, 18:2452-2461.
6. Leggett B., Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010, 138:2088-2100.
7. Chow E., Lipton L., Lynch E., et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006, 131:30-39.
8. Ferrández A., Samowitz W., DiSario J.A., et al. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 2004, 99:2012-2018.
9. Lage P., Cravo M., Sousa R., et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol 2004, 99:1779-1784.
10. Rubio C.A., Stemme S., Jaramillo E., et al. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006, 38:266-270.
11. Rashid A., Houlihan P.S., Booker S., et al. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000, 119:323-332.
12. Benlloch S., Payá A., Alenda C., et al. Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology. J Mol Diagn 2006, 8:540-543.
13. Jeuken J.W., Cornelissen S.J., Vriezen M., et al. MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. Lab Invest 2007, 87:1055-1065.
14. Weisenberger D.J., Siegmund K.D., Campan M., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006, 38:787-793.
15. Carvajal-Carmona L.G., Howarth K.M., Lockett M., et al. Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol 2007, 212:378-385.
16. Chan T.L., Zhao W., Leung S.Y., et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003, 63:4878-4881.
17. Kambara T., Simms L.A., Whitehall V.L., et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004, 53:1137-1144.
18. Boparai K.S., Dekker E., Polak M.M., et al. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol 2011, 178:2700-2707.
19. Vasen H.F., Watson P., Mecklin J.P., et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999, 116:1453-1456.
20. Boland C.R., Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010, 138:2073-2087.
21. Piñol V., Castells A., Andreu M., et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005, 293:1986-1994.
22. Beach R., Chan A.O., Wu T.T., et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 2005, 166:1069-1075.
23. Rosenberg D.W., Yang S., Pleau D.C., et al. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res 2007, 67:3551-3554.
24. Jass J.R. Hyperplastic polyps and colorectal cancer: is there a link?. Clin Gastroenterol Hepatol 2004, 2:1-8.
25. Chan A.O., Broaddus R.R., Houlihan P.S., et al. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002, 160:1823-1830.
26. Minoo P., Baker K., Goswami R., et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006, 55:1467-1474.
27. Jass J.R. Gastrointestinal polyposes: clinical, pathological and molecular features. Gastroenterol Clin North Am 2007, 36:927-946. viii.
28. Kalady M.F., Jarrar A., Leach B., et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 2011, 54:164-170.